10x Genomics Inc (GB:0A88)

10x Genomics (0A88) Financial Statements


10x Genomics Financial Overview

10x Genomics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; 10x Genomics is scheduled to report earnings on August 2, 2023, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 134.28M$ 156.23M$ 131.07M$ 114.61M$ 114.50M
Gross Profit$ 98.39M$ 119.41M$ 100.69M$ 86.91M$ 89.02M
EBIT$ -53.50M$ -19.10M$ -39.92M$ -63.72M$ -41.57M
EBITDA$ -44.89M$ -10.42M$ -31.81M$ -55.28M$ -33.59M
Net Income Common Stockholders$ -50.75M$ -17.21M$ -41.91M$ -64.46M$ -42.41M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 420.79M$ 432.58M$ 452.39M$ 499.73M$ 539.32M
Total Assets$ 1.01B$ 1.03B$ 996.21M$ 1.00B$ 1.00B
Total Debt$ 102.04M$ 95.18M$ 96.23M$ 99.02M$ 101.17M
Net Debt$ -318.75M$ -337.41M$ -356.16M$ -400.72M$ -438.15M
Total Liabilities$ 211.65M$ 1.03B$ 220.41M$ 218.07M$ 196.57M
Stockholders Equity$ 802.38M$ 805.74M$ 775.79M$ 783.52M$ 806.68M
Cash Flow-
Free Cash Flow$ -9.41M$ -26.01M$ -46.14M$ -44.18M$ -48.94M
Operating Cash Flow$ -4.13M$ 13.72M$ -9.56M$ -16.96M$ -20.80M
Investing Cash Flow$ 119.96M$ -33.17M$ -32.63M$ -27.53M$ -257.56M
Financing Cash Flow$ -3.41M$ 5.00M$ 2.04M$ 6.36M$ 2.42M
Currency in USD

10x Genomics Earnings and Revenue History

10x Genomics Debt to Assets

10x Genomics Cash Flow

10x Genomics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis